PharmaEngine, Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

45

Website

www.pharmaengine.com

Country

Taiwan

Exchange

Taipei Exchange

Taipei, Taiwan

PharmaEngine, Inc., a biopharmaceutical company develops drugs and therapeutic drugs for treating cancer in Taiwan. It offers ONIVYDE, a cancer medicine that blocks an enzyme called topoisomerase I, which is involved in copying cell DNA needed to make new cells.

The company is also developing PEP07, a CHK1 inhibitor, which is in Phase 1 clinical trial for the treatment of hematological tumors and solid tumors. Incorporated in 2002, PharmaEngine is headquartered in Taipei, Taiwan.

Key Stats

52-Week Range

NT$53.00NT$81.50

Beta0.15

Trailing P/E23.35

Forward P/E22.75

Trailing EPS2.69

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.